New CBD-Based Drug Offers Hope For Breast Cancer Patients Struggling With Pain: Clinical Trial Kicks Off
Cancer treatment and research center City of Hope and Biopharmaceutical Research Company, a pharmaceutical company that specializes in the development of proprietary cannabinoid therapeutics, announced on Thursday that the first patient has received BRC-001, an experimental supportive care therapy for breast cancer patients.
What Happened: The clinical trial, titled “High Cannabidiol (CBD) Standardized Extract for Aromatase Inhibitor-Induced Arthralgia – A randomized controlled double-blind clinical trial” seeks to assess the safety, tolerability and efficacy of a botanically-derived proprietary formulation developed by BRC (BRC-001) when taken orally to address the symptoms of AIIA.
City of Hope researchers are in the process of evaluating whether this cannabinoid therapeutic candidate could help patients with joint pain (arthralgia) that is often …